CerraCap — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Predicta Medpredicta-med.cominFeb 2023
Predicta Med develops a data analytics platform using deep learning to identify at-risk autoimmune disease patients across multiple medical systems, enabling clinicians to intervene earlier and improve diagnostic outcomes.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Shlomit
Co-investorsICONYC labsCerraCap Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.